Published in J Epidemiol Community Health on March 01, 1985
Traditional epidemiology, modern epidemiology, and public health. Am J Public Health (1996) 5.11
Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut (2001) 1.11
Cultural and economic determinants of geographical mortality patterns in The Netherlands. J Epidemiol Community Health (1991) 1.07
Social gradients in the health of Indigenous Australians. Am J Public Health (2011) 1.06
Case-control study of occupation and cancer of the prostate in New Zealand. J Epidemiol Community Health (1987) 0.89
Improving access to health care among New Zealand's Maori population. Am J Public Health (2006) 0.86
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
Social class, life expectancy and overall mortality. Milbank Mem Fund Q (1967) 7.19
Changing social-class distribution of heart disease. Br Med J (1978) 5.46
Socio-economic status, illness, and the use of medical services. Milbank Mem Fund Q (1957) 3.25
Socioeconomic status and mortality in the United States. Public Health Rep (1961) 2.90
Four-year mortality by some socioeconomic indicators: the Oslo study. J Epidemiol Community Health (1980) 2.48
A critical examination of the relationship between socioeconomic status and mortality. Am J Public Health Nations Health (1963) 2.30
Trends in coronary heart disease mortality and associated risk factors in New Zealand. N Z Med J (1981) 2.19
Social group and mortality in Finland. Br J Prev Soc Med (1977) 1.41
Mortality and social class in New Zealand. I: overall male mortality. N Z Med J (1983) 1.36
Socioeconomic differentials in mortality by cause of death. Health Serv Rep (1973) 1.14
Mortality and social class in New Zealand II: male mortality by major disease groupings. N Z Med J (1983) 1.07
Determinants of differences in mortality between New Zealand Maoris and non-Maoris aged 15-64. N Z Med J (1984) 1.03
Mortality and social class in New Zealand. III: male mortality by ethnic group. N Z Med J (1984) 0.91
The role of dairy products in the New Zealand diet. N Z Med J (1981) 0.83
Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med (1995) 4.82
Arsenic ingestion and internal cancers: a review. Am J Epidemiol (1992) 4.39
Diesel exhaust exposure and lung cancer. Epidemiology (1998) 4.08
Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol (1998) 4.07
Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med (1979) 3.54
Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology (1996) 3.49
Clues to cancer etiology from studies of farmers. Scand J Work Environ Health (1992) 2.98
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging (1992) 2.97
Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. Int J Epidemiol (1998) 2.92
Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect (1996) 2.83
Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology (2000) 2.67
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Research in cystic fibrosis (third of three parts). N Engl J Med (1976) 2.29
Trends in coronary heart disease mortality and associated risk factors in New Zealand. N Z Med J (1981) 2.19
Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol (1995) 2.19
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol (1995) 2.11
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest (1997) 2.10
Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res (1993) 2.03
Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int J Epidemiol (2000) 2.03
Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology (1992) 1.90
Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med (2008) 1.82
Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect. J Exp Med (1975) 1.82
Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci U S A (1975) 1.76
Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev (1994) 1.71
De-functioning stomas: a prospective controlled trial comparing loop ileostomy with loop transverse colostomy. Br J Surg (1986) 1.71
Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol (1990) 1.69
Consistent pattern of elevated symptoms in air-conditioned office buildings: a reanalysis of epidemiologic studies. Am J Public Health (1990) 1.66
Research in cystic fibrosis (second of three parts). N Engl J Med (1976) 1.66
Deaths from lung cancer and ischaemic heart disease due to passive smoking in New Zealand. N Z Med J (1989) 1.66
A large 4 pi plastic scintillator-detector with clinical applications. Int J Appl Radiat Isot (1967) 1.62
The distribution of cancer within the large bowel. Int J Cancer (1972) 1.62
Occupation, social class and male cancer mortality in New Zealand, 1974-78. Int J Epidemiol (1986) 1.61
Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev (1995) 1.60
Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol (2001) 1.59
Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol (1987) 1.54
Research in cystic fibrosis (first of three parts). N Engl J Med (1976) 1.52
Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med (2000) 1.52
Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst (1981) 1.52
Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health (1994) 1.52
Non-Hodgkin's lymphoma and farming: an expanded case-control study. Int J Cancer (1987) 1.51
Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax (2000) 1.51
Cognitive screening tests: an aid in the care of elderly outpatients. J Gen Intern Med (1990) 1.50
Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect (1996) 1.48
Relationship between complaints and quality of care in New Zealand: a descriptive analysis of complainants and non-complainants following adverse events. Qual Saf Health Care (2006) 1.46
Non-Hodgkin's lymphoma and exposure to phenoxyherbicides, chlorophenols, fencing work, and meat works employment: a case-control study. Br J Ind Med (1986) 1.46
Delayed health hazards of pesticide exposure. Annu Rev Public Health (1986) 1.45
Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am J Epidemiol (2006) 1.43
Soft tissue sarcoma and exposure to phenoxyherbicides and chlorophenols in New Zealand. J Natl Cancer Inst (1984) 1.37
Mortality and social class in New Zealand. I: overall male mortality. N Z Med J (1983) 1.36
Malignant lymphoma and multiple myeloma linked with agricultural occupations in a New Zealand Cancer Registry-based study. Am J Epidemiol (1985) 1.34
Dietary changes improve survival of CFTR S489X homozygous mutant mouse. Am J Physiol (1995) 1.34
Observations on the dose-response curve for arsenic exposure and lung cancer. Scand J Work Environ Health (1993) 1.34
Serum retinol and the inverse relationship between serum cholesterol and cancer. Br Med J (Clin Res Ed) (1982) 1.33
Arsenic in drinking water and bladder cancer. Cancer Invest (2000) 1.32
Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res (1997) 1.31
Influence of Salts in the Diet on the Intestinal Flora of the Albino Rat. J Bacteriol (1937) 1.31
The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis (1980) 1.31
An examination of the relationship between fluoridation of water and cancer mortality in 20 large US cities. N Z Med J (1980) 1.31
A review. Cystic fibrosis at forty--quo vadis? Pediatr Res (1980) 1.27
Autonomic nervous system abnormalities and allergy. Ann Intern Med (1982) 1.22
Placebo-controlled double-blind trial of mianserin hydrochloride. Br J Clin Pharmacol (1978) 1.21
Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol (2000) 1.21
Assisted ventilation for patients with cystic fibrosis. JAMA (1978) 1.20
Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis. N Engl J Med (1980) 1.18
Case-control study of multiple myeloma and farming. Br J Cancer (1986) 1.18
Intraocular melanoma linked to occupations and chemical exposures. Epidemiology (1996) 1.17
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics (1999) 1.17
Methodological issues in the epidemiology of electromagnetic fields and cancer. Epidemiol Rev (1989) 1.16
Family size, infections, and asthma prevalence in New Zealand children. Epidemiology (1999) 1.12
Decreased adenosine 3':5'-monophosphate response to isoproterenol in cystic fibrosis leukocytes. Pediatr Res (1978) 1.11
A single conductance pore for chloride ions formed by two cystic fibrosis transmembrane conductance regulator molecules. J Biol Chem (1999) 1.10
Function of the R domain in the cystic fibrosis transmembrane conductance regulator chloride channel. J Biol Chem (1997) 1.10
Long term changes in total body water, total exchangable sodium and total body potassium before and after ileostomy. Br J Surg (1975) 1.08
Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med (1981) 1.08
Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J Clin Invest (1995) 1.08
Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev (1997) 1.08
A standardized benchmark approach to the use of cancer epidemiology data for risk assessment. Toxicol Ind Health (1985) 1.07
Changes in the Structure of the Developing Tooth in Rats Maintained on a Diet Deficient in Vitamin A. Yale J Biol Med (1941) 1.07
Cancer case-control studies with other cancers as controls. Int J Epidemiol (1988) 1.07
Congenital defects and miscarriages among New Zealand 2, 4, 5-T sprayers. Arch Environ Health (1982) 1.07
Mortality and social class in New Zealand II: male mortality by major disease groupings. N Z Med J (1983) 1.07
Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Implications for antiinflammatory therapy in cystic fibrosis. Am Rev Respir Dis (1990) 1.07
Dental Changes in Rats Consuming a Diet Poor in Inorganic Salts. Yale J Biol Med (1936) 1.06
The New Zealand cancer registry. N Z Med J (1977) 1.05
Cross-calibration of GE/Lunar pencil and fan-beam dual energy densitometers--bone mineral density and body composition studies. Eur J Clin Nutr (2003) 1.04
Use of unabsorbed radioactive marker substances in a re-assessment of the radioactive triolein test of fat absorption. J Clin Pathol (1971) 1.04
Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy (2003) 1.03
Determinants of differences in mortality between New Zealand Maoris and non-Maoris aged 15-64. N Z Med J (1984) 1.03